Tickwind
TodayOpportunitiesMarketsHotNewsAI Chat
What's new
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Stocks

LLYELI LILLY & Co

Pharmaceutical Preparations

US
Waiting for a price…
Add to watchlist
More on LLY
Quant ratingFair value (DCF)vs peersGrowth of $10,000Filing changesOption chainAI deep research

AI Deep Research

AI generated

A source-attributed, AI-written analyst report for LLY.

Every figure is drawn from public filings — the AI writes the analysis, never the numbers.

Dividends

How the company returns cash to shareholders — from its latest annual SEC filings.

Annual figures from SEC filings · descriptive, not a dividend-safety rating or advice. Delayed data.

Price & indicators

MA5MA10MA20MA60· MACD · RSI · VOL

Daily OHLC · MA/MACD/RSI computed locally. Not investment advice.

Key statistics

FY2025

Reference figures from the latest SEC filings (FY2025).

ELI LILLY & Co (LLY) key statistics
Market cap$1.15T
P/E (TTM)43.2
P/B36.72
Dividend yield0.47%
Revenue (TTM)$72.25B
Rev. growth (YoY)+44.7%
Net income (TTM)$25.28B
Net margin (TTM)35.0%
EPS, diluted (TTM)$28.15
52-week range$623.78 – $1249.45
Next earningsAug 5, 2026

Figures from SEC filings · delayed prices · for reference only · not investment advice

Growth of $10,000

Signal Backtest

Try one backtest free — see how the golden-cross signal performed on this stock.

Sign in to run a free backtest

Historical statistic over past daily data — how this rule behaved before, not a prediction or advice.

Relative Strength

Trailing return vs the S&P 500 (SPY) — positive means it outperformed the market.

Trailing price performance vs SPY — a disclosed historical statistic, not a forecast or advice. Delayed data.

Earnings Reaction

How the price has historically moved around past earnings announcements.

A ~2-session move spanning each earnings date — a disclosed historical statistic, not a forecast or advice. Delayed data.

Factor Scorecard

Percentile rank vs Tickwind’s tracked universe — higher = stronger on that factor.

Percentile rank vs Tickwind’s tracked universe. The letter grades are a plain relabeling of these descriptive percentiles; the headline Quant Rating is a disclosed mechanical mapping of the composite percentile — a relative quantitative signal, not personalized investment advice. Delayed data.

Quality Checks

Two published academic scores computed from SEC filings — itemized, descriptive, not a rating.

Computed from SEC XBRL filings via published academic formulas (Piotroski 2000; Altman 1968). Zone names are the papers’ published band labels. Descriptive — not a rating, prediction, or investment advice.

Seasonality

Average return by calendar month over the available years.

Historical average monthly returns — a disclosed statistic, not a forecast or advice. Delayed data.

Log in to track LLY and save links

Keep a watchlist and clip posts from anywhere — free.

Log in
LLY financial trends
RevenueNet incomeNet marginOperating cash flowReturn on equityStock buybacksDividends paidTotal assetsTotal liabilitiesShareholders’ equity

Filings & news

Latest SEC filings and headlines for ELI LILLY & Co (LLY).

Latest SEC filings

  • 25-NSENotification of delistingJun 2, 2026
  • 144Notice of proposed sale (Form 144)May 28, 2026
  • 144Notice of proposed sale (Form 144)May 22, 2026

Latest headlines

  • Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

    Yahoo · Jun 7, 2026

  • Dow Jones Futures Due Amid Market Rally's First Real Test; SpaceX IPO, Apple, Oracle Ahead

    Yahoo · Jun 7, 2026

  • 80% of Wegovy Pill Users Never Took a Weight Loss Drug Before. Does This Number Change the Entire Novo Nordisk Bear Case?

    Yahoo · Jun 7, 2026

Figures from SEC filings · delayed prices · for reference only · not investment advice

Related to LLY

Compare

LLY vs NVOLLY vs PFELLY vs MRKLLY vs ABBV

Related stocks

NVOPFEMRKABBV

Theme zones

GLP-1 & Obesity